Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma

This study has been completed.
Henrik Jensen, Dept. of Oncology, Vejle Sygehus, Vejle, Denmark
Information provided by:
Rigshospitalet, Denmark Identifier:
First received: July 10, 2006
Last updated: August 25, 2008
Last verified: August 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2008
  Estimated Primary Completion Date: No date given